The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation

Frontiers in Pharmacology

Volumn 3 JUN, Issue , 2012, Pages

  Kousik, Sharanya M ^a   Napier, T Celeste ^a   Carvey, Paul M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood brain barrier; Cocaine; HIV; Mdma; Methamphetamine; Neuroinflammation; Nicotine

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARBOXYLASE; CD31 ANTIGEN; CLAUDIN 5; COCAINE; DOPAMINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; JUNCTIONAL ADHESION MOLECULE B; METHAMPHETAMINE; MONOCARBOXYLASE; MULTIDRUG RESISTANCE PROTEIN; NICOTINE; OCCLUDIN; ORGANIC CATION TRANSPORTER; PROTEIN ZO1; PSYCHOSTIMULANT AGENT; REACTIVE OXYGEN METABOLITE; SEROTONIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; BRAIN REGION; CELL ACTIVATION; CELL ADHESION; CELL COUNT; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; COMORBIDITY; DISEASE ASSOCIATION; DRUG ABUSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHERMIA; INFECTION RISK; LEUKOCYTE MIGRATION; MEMBRANE PERMEABILITY; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; SEXUAL BEHAVIOR; SIGNAL TRANSDUCTION; VIRUS ENTRY; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 84866180243     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00121     Document Type: Article

References (175)

1. Abbott, N. J., Patabendige, A. A., Dolman, D. E., Yusof, S. R., and Begley, D. J. (2010). Structure and function of the blood-brain barrier. Neurobiol Dis. 37, 13-25.
2. Abbruscato, T. J., Lopez, S. P., Mark, K. S., Hawkins, B. T., and Davis, T. P. (2002). Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. J. Pharm. Sci. 91, 2525-2538.
3. Abbruscato, T. J., Lopez, S. P., Roder, K., and Paulson, J. R. (2004). Regulation of blood-brain barrier Na, K, 2Clcotransporter through phosphorylation during in vitro stroke conditions and nicotine exposure. J. Pharmacol Exp. Ther. 310, 459-468.
4. Abbud, R. A., Finegan, C. K., Guay, L. A., and Rich, E. A. (1995). Enhanced production of human immunodeficiency virus type 1 by in vitroinfected alveolar macrophages from otherwise healthy cigarette smokers. J. Infect. Dis. 172, 859-863.
5. Abdul Muneer, P. M., Alikunju, S., Szlachetka, A. M., Murrin, L. C., and Haorah, J. (2011). Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction. Mol. Neurodegener. 6, 23.
6. Aksenov, M. Y., Aksenova, M. V., Silvers, J. M., Mactutus, C. F., and Booze, R. M. (2008). Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons. Neurotoxicology 29, 971-977.
7. Albaugh, G., Bellavance, E., Strande, L., Heinburger, S., Hewitt, C. W., and Alexander, J. B. (2004). Nicotine induces mononuclear leukocyte adhesion and expression of adhesion molecules, VCAM and ICAM, in endothelial cells in vitro. Ann. Vasc. Surg. 18, 302-307.
8. An, S. F., Groves, M., Gray, F., and Scaravilli, E (1999). Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J. Neuropathol. Exp. Neurol. 58, 1156-1162.
9. Bagetta, G., Piccirilli, S., Del Duca, C., Morrone, L. A., Rombola, L., Nappi, G., De Alba, J., Knowles, R. G., and Corasaniti, M. T. (2004). Inducible nitric oxide synthase is involved in the mechanisms of cocaine enhanced neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. Neurosci. Lett. 356, 183-186.
10. Bandopadhyay, R., Orte, C., Lawrenson, J. G., Reid, A. R., De, S. S., and Allt, G. (2001). Contractile proteins in pericytes at the blood-brain and bloodretinal barriers. J. Neurocytol. 30, 35-44.
11. Banerjee, A., Zhang, X., Manda, K. R., Banks, W. A., and Ercal, N. (2010). HIV proteins (gp120 and Tat) and methamphetamine in oxidative stressinduced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide. Free Radic. Biol. Med. 48, 1388-1398.
12. Barnett, G., Hawks, R., and Resnick, R. (1981). Cocaine pharmacokinetics in humans. J. Ethnopharmacol. 3, 353-366.
13. Barroso-Moguel, R., Villeda-Hernández, J., Méndez-Armenta, M., and Ríos, C. (1997). Brain capillary lesions produced by cocaine in rats. Toxicol. Lett. 92, 9-14.
14. Baum, M. K., Rafie, C., Lai, S., Sales, S., Page, B., and Campa, A. (2009). Crackcocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J. Acquir. Immune Defic. Syndr. 50, 93-99.
15. Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., and Zlokovic, B. V (2010). Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409-427.
16. Bennett, B. A., Hyde, C. E., Pecora, J. R., and Clodfelter, J. E. (1993). Differing neurotoxic potencies of methamphetamine, mazindol, and cocaine in mesencephalic cultures. J. Neurochem. 60, 1444-1452.
17. Berger, J. R., and Nath, A. (1997). HIV dementia and the basal ganglia. Intervirology 40, 122-131.
18. Bowyer, J. F., and Ali, S. E (2006). High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 60, 521-532.
19. Bowyer, J. F., Thomas, M., Schmued, L. C., and Ali, S. E (2008). Brain regionspecific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures, and the blood-brain barrier. Ann. N. Y. Acad. Sci. 1139, 127-139.
20. Bradford, S. T., Stamatovic, S. M., Dondeti, R. S., Keep, R. F., and Andjelkovic, A. V (2011). Nicotine aggravates the brain postischemic inflammatory response. Am. J. Physiol. Heart Circ. Physiol. 300, H1518-H1529.
21. Buch, S., Yao, H., Guo, M., Mori, T., Su, T. P., and Wang, J. (2011). Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction. J. Neuroimmune Pharmacol. 6, 503-515.
22. Buchacz, K., McFarland, W., Kellogg, T. A., Loeb, L., Holmberg, S. D., Dilley, J., and Klausner, J. D. (2005). Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 19, 1423-1424.
23. Buckner, D., Wilson, S., Kurk, S., Hardy, M., Miessner, N., and Jutila, M. A. (2006). Use of early passage fetalintestinal epithelial cells in semihighthroughput screening assays: an approach to identify new innate immune system adjuvants. J. Biomol. Screen 11, 664-671.
24. Burkhalter, J. E., Springer, C. M., Chhabra, R., Ostroff, J. S., and Rapkin, B. D. (2005). Tobacco use and readiness toquit smoking in lowincome HIV-infected persons. Nicotine Tob. Res. 7, 511-522.
25. Cadet, J. L., Sheng, P., Ali, S. F., Rothman, R., Carlson, E., and Epstein, C. (1994). Attenuation of methamphetamineinduced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62, 380-383.
26. Callaghan, R. C., Cunningham, J. K., Sykes, J., and Kish, S. J. (2012). Increased risk of Parkinson's disease inindividuals hospitalized with conditions related to the use of methamphetamine or other amphetaminetype drugs. Drug Alcohol Depend. 120, 35-40.
27. Canis, M., Mack, B., Gires, O., Maurer, M. H., Kuschinsky, W., Duembgen, L., and Duelli, R. (2009). Increased densitiesof monocarboxylate transport protein MCT1 after chronic administration of nicotine in rat brain. Neurosci. Res. 64, 429-435.
28. Cartier, L., Hartley, O., Dubois-Dauphin, M., and Krause, K. H. (2005). Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 48, 16-42.
29. Carvey, P. M., Hendey, B., and Monahan, A. J. (2009). The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J. Neurochem. 111, 291-314.
30. Chaisson, R. E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M. A., and Moss, A. R. (1989). Cocaine use and HIVinfection in intravenous drug users in San Francisco. JAMA 261, 561-565.
31. Chang, L., Ernst, T., Speck, O., and Grob, C. S. (2005). Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am. J. Psychiatry 162, 361-369.
32. Chang, S. L., Bersig, J., Felix, B., Fiala, M., and House, S. D. (2000). Chronic cocaine alters hemodynamics and leukocyteendothelial interactions in rat mesenteric venules. Life Sci. 66, 2357-2369.
33. Chen, Y. H., Chen, S. H., Jong, A., Zhou, Z. Y., Li, W., Suzuki, K., and Huang, S. H. (2002). Enhanced Escherichia coli invasion of human brain microvascular endothelial cells is associated with alternations in cytoskeleton induced by nicotine. Cell. Microbiol. 4, 503-514.
34. Collins, R. L., Kanouse, D. E., Gifford, A. L., Senterfitt, J. W., Schuster, M. A., McCaffrey, D. F., Shapiro, M. F., andWenger, N. S. (2001). Changes in healthpromoting behavior following diagnosis with HIV: prevalence and correlates in a national probability sample. Health Psychol. 20, 351-360.
35. Compston, A., and Coles, A. (2008). Multiple sclerosis. Lancet 372, 1502-1517.
36. Conant, K., McArthur, J. C., Griffin, D. E., Sjulson, L., Wahl, L. M., and Irani, D. N. (1999). Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann. Neurol. 46, 391-398.
37. Conant, K., St Hillaire, C., Anderson, C., Galey, D., Wang, J., and Nath, A. (2004). Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrixdegrading proteinases. J. Neurovirol. 10, 21-28.
38. Conklin, B. S., Zhao, W., Zhong, D. S., and Chen, C. (2002). Nicotine and cotinine upregulate vascular endothelialgrowth factor expression in endothelial cells. Am. J. Pathol. 160, 413-418.
39. Conley, L. J., Bush, T. J., Buchbinder, S. P., Penley, K. A., Judson, E N., and Holmberg, S. D. (1996). The associationbetween cigarette smoking and selected HIV-related medical conditions. AIDS 10, 1121-1126.
40. Connolly, G. N., Alpert, H. R., Wayne, G. F., and Koh, H. (2007). Trends in nicotine yield in smoke and its relationshipwith design characteristics among popular US cigarette brands, 1997-2005. Tob. Control. 16, e5.
41. Cook, J. A., Burke-Miller, J. K., Cohen, M. H., Cook, R. L., Vlahov, D., Wilson, T. E., Golub, E. T., Schwartz, R. M., Howard, A. A., Ponath, C., Plankey, M. W., Levine, A., and Grey, D. D. (2008). Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 22, 1355-1363.
42. Couraud, P. O. (1998). Infiltration of inflammatory cells through brain endothelium. Pathol. Biol. 46, 176-180.
43. Czub, S., Koutsilieri, E., Sopper, S., Czub, M., Stahl-Hennig, C., Muller, J. G., Pedersen, V., Gsell, W., Heeney, J. L., Gerlach, M., Gosztonyi, G., Riederer, P., and Ter Meulen, V (2001). Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol. 101, 85-91.
44. de la Monte, S. M., Longato, L., Tong, M., De Nucci, S., and Wands, J. R. (2009). The liverbrain axis of alcoholmediated neurodegeneration: role of toxic lipids. Int. J. Environ. Res. Public Health 6, 2055-2075.
45. Deli, M. A., Dehouck, M. P., Cecchelli, R., Abraham, C. S., and Joo, E (1995). Histamine induces a selective albuminpermeation through the blood-brain barrier in vitro. Inflamm. Res. 44(Suppl. 1), S56-S57.
46. Dhillon, N. K., Peng, F., Bokhari, S., Callen, S., Shin, S. H., Zhu, X., Kim, K. J., and Buch, S. J. (2008). Cocainemediated alteration in tight junction protein expression and modulation of CCL2/CCR2 axis across the blood-brain barrier: implications for HIV-dementia. J. Neuroimmune Pharmacol. 3, 52-56.
47. Diaz-Flores, L., Gutierrez, R., Varela, H., Rancel, N., andValladares, F. (1991). Microvascular pericytes: a review of their morphological and functional characteristics. Histol Histopathol. 6, 269-286.
48. Dunn, M., Day, C., Bruno, R., Degenhardt, L., and Campbell, G. (2010). Sexual and injecting risk behaviours among regular ecstasy users. Addict. Behav. 35, 157-160.
49. Farkas, E., and Luiten, P. G. (2001). Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64, 575-611.
50. Feldman, J. G., Minkoff, H., Schneider, M. F., Gange, S. J., Cohen, M., Watts, D. H., Gandhi, M., Mocharnuk, R. S., andAnastos, K. (2006). Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am. J. Public Health 96, 1060-1065.
51. Fiala, M., Eshleman, A. J., Cashman, J., Lin, J., Lossinsky, A. S., Suarez, V., Yang, W., Zhang, J., Popik, W., Singer, E., Chiappelli, F., Carro, E., Weinand, M., Witte, M., and Arthos, J. (2005). Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J. Neurovirol. 11, 281-291.
52. Fiala, M., Gan, X. H., Newton, T., Chiappelli, F., Shapshak, P., Kermani, V., Kung, M. A., Diagne, A., Martinez, O., Way, D., Weinand, M., Witte, M., and Graves, M. (1996). Divergent effects of cocaine on cytokine production by lymphocytes and monocyte/macrophages: HIV-1 enhancement by cocaine within the blood-brain barrier. Adv. Exp. Med. Biol. 402, 145-156.
53. Fiala, M., Gan, X. H., Zhang, L., House, S. D., Newton, T., Graves, M. C., Shapshak, P., Stins, M., Kim, K. S., Witte, M., and Chang, S. L. (1998). Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? Adv. Exp. Med. Biol. 437, 199-205.
54. Fiala, M., Singer, E. J., Commins, D., Mirzapoiazova, T., Verin, A., Espinosa, A., Ugen, K., Bernas, M., Witte, M., Weinand, M., and Lossinsky, A. S. (2008). HIV-1 Antigens in neurons of cocaineabusing patients. Open Virol. J. 2, 24-31.
55. Fletcher, N. F., Bexiga, M. G., Brayden, D. J., Brankin, B., Willett, B. J., Hosie, M. J., Jacque, J. M., and Callanan, J. J. (2009). Lymphocyte migration through the blood-brain barrier (BBB) in feline immunodeficiency virus infection is significantly influenced by the preexistence of virus and tumour necrosis factor (TNF)-alpha within the central nervous system (CNS): studies using an in vitro feline BBB model. Neuropathol. Appl. Neurobiol. 35, 592-602.
56. Gan, X., Zhang, L., Berger, O., Stins, M. F., Way, D., Taub, D. D., Chang, S. L., Kim, K. S., House, S. D., Weinand, M., Witte, M., Graves, M. C., and Fiala, M. (1999). Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin. Immunol. 91, 68-76.
57. Gandhi, N., Saiyed, Z. M., Napuri, J., Samikkannu, T., Reddy, P. V., Agudelo, M., Khatavkar, P., Saxena, S. K., and Nair, M. P. (2010). Interactive role of human immunodeficiency virus type 1 (HIV-1) cladespecific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder. J. Neurovirol. 16, 294-305.
58. Garden, G. A. (2002). Microglia in human immunodeficiency virusassociated neurodegeneration. Glia 40, 240-251.
59. Gerzanich, V., Ivanova, S., and Simard, J. M. (2003). Early pathophysiological changes in cerebral vessels predisposing tostroke. Clin. Hemorheol. Microcirc. 29, 291-294.
60. Gavrilin, M. A., Mathes, L. E., and Podell, M. (2002). Methamphetamine enhances cellassociated feline immunodeficiency virus replication in astrocytes. J. Neurovirol. 8, 240-249.
61. Goncalves, J., Baptista, S., Martins, T., Milhazes, N., Borges, F., Ribeiro, C. F., Malva, J. O., and Silva, A. P. (2010). Methamphetamineinduced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur. J. Neurosci. 31, 315-326.
62. Goncalves, J., Martins, T., Ferreira, R., Milhazes, N., Borges, F., Ribeiro, C. F., Malva, J. O., Macedo, T. R., and Silva, A. P. (2008). Methamphetamineinduced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain. Ann. N Y. Acad. Sci. 1139, 103-111.
63. Gritz, E. R., Vidrine, D. J., Lazev, A. B., Amick, B. C. III, and Arduino, R. C. (2004). Smoking behavior in a lowincome multiethnic HIV/AIDS population. Nicotine Tob. Res. 6, 71-77.
64. Gu, Y., Zheng, G., Xu, M., Li, Y., Chen, X., Zhu, W., Tong, Y., Chung, S. K., Liu, K. J., and Shen, J. (2012). Caveolin-1 regulates nitric oxidemediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J. Neurochem. 120, 147-156.
65. Guilartem, T. R., Nihei, M. K., McGlothan, J. L., and Howard, A. S. (2003). Methamphetamineinduced deficits of brainmonoaminergic neuronal markers: distal axotomy or neuronal plasticity. Neuroscience 122, 499-513.
66. Hawkins, B. T., Abbruscato, T. J., Egleton, R. D., Brown, R. C., Huber, J. D., Campos, C. R., and Davis, T. P. (2004). Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res. 1027, 48-58.
67. Hawkins, B. T., and Davis, T. P. (2005). The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57, 173-185.
68. Hawkins, B. T., Egleton, R. D., and Davis, T. P. (2005). Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. Am. J. Physiol. Heart Circ. Physiol. 289, H212-H219.
69. Hirschtick, R. E., Glassroth, J., Jordan, M. C., Wilcosky, T. C., Wallace, J. M., Kvale, P. A., Markowitz, N., Rosen, M. J., Mangura, B. T., and Hopewell, P. C. (1995). Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N. Engl. J. Med. 333, 845-851.
70. Humfleet, G. L., Delucchi, K., Kelley, K., Hall, S. M., Dilley, J., and Harrison, G. (2009). Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges. AIDS Educ. Prev. 21, 54-64.
71. Hutamekalin, P., Farkas, A. E., Orbok, A., Wilhelm, I., Nagyoszi, P., Veszelka, S., Deli, M. A., Buzas, K., Hunyadi-Gulyas, E., Medzihradszky, K. F., Meksuriyen, D., and Krizbai, I. A. (2008). Effect of nicotine and polyaromtic hydrocarbons on cerebral endothelial cells. Cell Biol. Int. 32, 198-209.
72. Iadecola, C. (2004). Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5, 347-360.
73. Janzer, R. C., and Raff, M. C. (1987). Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325, 253-257.
74. Kiyatkin, E. A., Brown, P. L., and Sharma, H. S. (2007). Brain edema and breakdown of the blood-brain barrier duringmethamphetamine intoxication: critical role of brain hyperthermia. Eur. J. Neurosci. 26, 1242-1253.
75. Kiyatkin, E. A., and Sharma, H. S. (2009). Acute methamphetamine intoxication: brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities. Int. Rev. Neurobiol. 88, 65-100.
76. Kiyatkin, E. A., and Sharma, H. S. (2011). Expression of heat shock protein (HSP 72 kDa) during acute methamphetamine intoxication depends on brain hyperthermia: neurotoxicity or neuroprotection? J. Neural. Transm. 118, 47-60.
77. Klitzman, R. L., Greenberg, J. D., Pollack, L. M., and Dolezal, C. (2002). MDMA ("ecstasy") use, and its association withhigh risk behaviors, mental health, and other factors among gay/bisexual men in New York City. Drug Alcohol Depend. 66, 115-125.
78. Koehler, R. C., Roman, R. J., and Harder, D. R. (2009). Astrocytes and the regulation of cerebral blood flow. Trends Neurosci. 32, 160-169.
79. Kousik, S. M., Graves, S. M., Napier, T. C., Zhao, C., and Carvey, P. M. (2011). Methamphetamineinduced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport 22, 923-928.
80. Koutsilieri, E., Gotz, M. E., Sopper, S., Sauer, U., Demuth, M., Ter Meulen, V., and Riederer, P. (1997). Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro. J. Neurovirol. 3, 342-349.
81. Krasnova, I. N., and Cadet, J. L. (2009). Methamphetamine toxicity and messengers of death. Brain Res. 60, 379-407.
82. Krueger, M., and Bechmann, I. (2010). CNS pericytes: concepts, misconceptions, and a way out. Glia 58, 1-10.
83. Kuhn, D. M., Francescutti-Verbeem, D. M., and Thomas, D. M. (2006). Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamineinduced nerve ending damage. Ann. N. Y. Acad. Sci. 1074, 31-41.
84. Kuroda, K. O., Ornthanalai, V G., Kato, T., and Murphy, N. P. (2010). FosB null mutant mice show enhancedmethamphetamine neurotoxicity: potential involvement of FosB in intracellular feedback signaling and astroglial function. Neuropsychopharmacology 35, 641-655.
85. Lai, Y. T., Tsai, Y. P., Cherng, C. G., Ke, J. J., Ho, M. C., Tsai, C. W., and Yu, L. (2009). Lipopolysaccharide mitagates methamphetamineinduced striatal dopamine depletion via modulating local TNF-alpha and dopamine transporter expression. J. Neural Transm. 116, 405-415.
86. Le, H. J. (2003). Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. Int. J. Tuberc. Lung Dis. 7, 811-819.
87. Lecrux, C., and Hamel, E. (2011). The neurovascular unit in brain function and disease. Acta Physiol. (Oxf. ) 203, 47-59.
88. Lee, Y. W., Hennig, B., Fiala, M., Kim, K. S., and Toborek, M. (2001). Cocaine activates redoxregulated transcription factors and induces TNF-alpha expression in human brain endothelial cells. Brain Res. 920, 125-133.
89. Letendre, S., Paulino, A. D., Rockenstein, E., Adame, A., Crews, L., Cherner, M., Heaton, R., Ellis, R., Everall, I. P., Grant, I., and Masliah, E. (2007). Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J. Infect. Dis. 196, 361-370.
90. Letendre, S. L., Cherner, M., Ellis, R. J., Marquie-Beck, J., Gragg, B., Marcotte, T., Heaton, R. K., McCutchan, J. A., and Grant, I. (2005). The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS 19(Suppl. 3), S72-S78.
91. Liang, H., Wang, X., Chen, H., Song, L., Ye, L., Wang, S. H., Wang, Y. J., Zhou, L., and Ho, W Z. (2008). Methamphetamine enhances HIV infection of macrophages. Am. J. Pathol. 172, 1617-1624.
92. Lin, S. J., Hong, C. Y., Chang, M. S., Chiang, B. N., and Chien, S. (1992). Longterm nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. Arterioscler. Thromb. 12, 1305-1312.
93. Liou, H. H., Hsu, H. J., Tsai, Y. F., Shih, C. Y., Chang, Y C, and Lin, C. J. (2007). Interaction between nicotine and MPTP/MPP+ in rat brain endothelial cells. Life Sci. 81, 664-672.
94. Liuzzi, G. M., Mastroianni, C. M., Latronico, T., Mengoni, F., Fasano, A., Lichtner, M., Vullo, V., andRiccio, P. (2004). Anti-HIV drugs decrease the expression of matrixmetalloproteinases in astrocytes and microglia. Brain 127, 398-407.
95. Lockman, P. R., Van der Schyf, C. J., Abbruscato, T. J., and Allen, D. D. (2005). Chronic nicotine exposure alters blood-brain barrier permeability and diminishes brain uptake of methyllycaconitine. J. Neurochem. 94, 37-44.
96. Madsen, S. J., and Hirschberg, H. (2010). Sitespecific opening of the blood-brain barrier. JBiophotonics 3, 356-367.
97. Mahajan, S. D., Aalinkeel, R., Sykes, D. E., Reynolds, J. L., Bindukumar, B., Adal, A., Qi, M., Toh, J., Xu, G., Prasad, P. N., and Schwartz, S. A. (2008). Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res. 1203, 133-148.
98. Manda, V K., Mittapalli, R. K., Bohn, K. A., Adkins, C. E., and Lockman, P. R. (2010a). Nicotine and cotinine increases the brain penetration of saquinavir in rat. J. Neurochem. 115, 1495-1507.
99. Manda, V K., Mittapalli, R. K., Geldenhuys, W J., and Lockman, P. R. (2010b). Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrity. J. Neurochem. 115, 515-525.
100. Maragos, W. F., Young, K. L., Turchan, J. T., Guseva, M., Pauly, J. R., Nath, A., and Cass, W A. (2002). Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J. Neurochem. 83, 955-963.
101. Mark, K. S., and Davis, T. P. (2002). Cerebral microvascular changes in permeability and tight junctions induced by hypoxiareoxygenation. Am. J. Physiol. Heart Circ. Physiol. 282, H1485-H1494.
102. Martins, T., Baptista, S., Goncalves, J., Leal, E., Milhazes, N., Borges, F., Ribeiro, C. F., Quintela, O., Lendoiro, E., Lopez-Rivadulla, M., Ambrosio, A. F., and Silva, A. P. (2011). Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9. Brain Res. 1411, 28-40.
103. McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., and Brasic, J. (2008). Persistent cognitive anddopamine transporter deficits in abstinent methamphetamine users. Synapse 62, 91-100.
104. Mitcheson, L., McCambridge, J., Byrne, A., Hunt, N., and Winstock, A. (2008). Sexual health risk among dance drug users: crosssectional comparisons with nationally representative data. Int. J. Drug Policy 19, 304-310.
105. Monks, T. J., Jones, D. C., Bai, E, and Lau, S. S. (2004). The role of metabolism in 3, 4-(+)-methylenedioxyamphetamine and 3, 4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity. Ther. Drug. Monit. 26, 132-136.
106. Morgan, M. E., and Gibb, J. W. (1980). Shortterm and longterm effects of methamphetamine on biogenic amine metabolism in extrastriatal dopaminergic nuclei. Neuropharmacology 19, 989-995.
107. Morganti-Kossman, M. C., Lenzlinger, P. M., Hans, V., Stahel, P., Csuka, E., Ammann, E., Stocker, R., Trentz, O., and Kossmann, T. (1997). Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol. Psychiatry 2, 133-136.
108. Nair, M. P., Saiyed, Z. M., Nair, N., Gandhi, N. H., Rodriguez, J. W., Boukli, N., Provencio-Vasquez, E., Malow, R. M., and Miguez-Burbano, M. J. (2009). Methamphetamine enhances HIV-1 infectivityinmonocyte derived dendritic cells. J Neuroimmune Pharmacol 4, 129-139.
109. Nair, M. P., Schwartz, S. A., Mahajan, S. D., Tsiao, C., Chawda, R. P., Whitney, R., Don Sykes, B. B., and Hewitt, R. (2004). Drug abuse and neuropathogenesis of HIV infection: role of DC-SIGN and IDO. J. Neuroimmunol. 157, 56-60.
110. Napier, T. C., Zhang, J., and Hu, X. T. (2010). HIV-1 Tat Dysregulates Activity ofRat mPFC PyramidalNeurons via Up-Regulating L-Type Calcium Channels. Program No. 764. 2. 2010 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience.
111. Nash, J. F., and Yamamoto, B. K. (1992). Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3, 4-methylenedioxymethamphetamine. Brain Res. 581, 237-243.
112. Nath, A. (2010). Human immunodeficiency virusassociated neurocognitive disorder: pathophysiology in relation to drugaddiction. Ann. N. Y. Acad. Sci. 1187, 122-128.
113. Nath, A., Haughey, N. J., Jones, M., Anderson, C., Bell, J. E., and Geiger, J. D. (2000). Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 47, 186-194.
114. Nath, A., Hauser, K. F., Wojna, V., Booze, R. M., Maragos, W., Prendergast, M., Cass, W., and Turchan, J. T. (2002). Molecular basis for interactions of HIV and drugs of abuse. J. Acquir. Immune Defic. Syndr. 31(Suppl. 2), S62-S69.
115. Nath, A., Maragos, W. F., Avison, M. J., Schmitt, E A., and Berger, J. R. (2001). Acceleration of HIV dementia with methamphetamine and cocaine. J. Neurovirol. 7, 66-71.
116. Ohtsuki, S. (2004). Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system. Yakugaku Zasshi 124, 791-802.
117. Orio, L., O'Shea, E., Sanchez, V., Pradillo, J. M., Escobedo, I., Camarero, J., Moro, M. A., Green, A. R., and Colado, M. I. (2004). 3, 4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion. J. Neurochem. 89, 1445-1453.
118. O'Shea, E., Sanchez, V., Orio, L., Escobedo, I., Green, A. R., and Colado, M. I. (2005). 3, 4-Methylenedioxymethamphetamine increases prointerleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of dark agouti rats: role of interleukin-1beta in neurotoxicity. Neuroscience 135, 1095-1105.
119. Paulson, J. R., Roder, K. E., McAfee, G., Allen, D. D., Van der Schyf, C. J., and Abbruscato, T. J. (2006). Tobacco smoke chemicals attenuate braintoblood potassium transport mediated by the Na, K, 2Clcotransporter during hypoxiareoxygenation. J. Pharmacol. Exp. Ther. 316, 248-254.
120. Paulson, J. R., Yang, T., Selvaraj, P. K., Mdzinarishvili, A., Van der Schyf, C. J., Klein, J., Bickel, U., and Abbruscato, T. J. (2010). Nicotine exacerbates brain edema during in vitro and in vivo focal ischemic conditions. J. Pharmacol. Exp. Ther. 332, 371-379.
121. Peppiatt, C. M., Howarth, C., Mobbs, P., and Attwell, D. (2006). Bidirectional control of CNS capillary diameter by pericytes. Nature 443, 700-704.
122. Perdisky, Y., Ho, W., Ramirez, S. H., Potula, R., Abood, M. E., Unterwald, E., and Tuma, R. (2011). HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions. Brain Behav. Immun. 25(Supp. 1), S61-S70.
123. Peterson, P. K., Gekker, G., Chao, C. C., Schut, R., Molitor, T. W., and Balfour, H. H. Jr. (1991). Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factorbeta. J. Immunol. 146, 81-84.
124. Petty, M. A., and Lo, E. H. (2002). Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol. 68, 311-323.
125. Price, T. O., Ercal, N., Nakaoke, R., and Banks, W. A. (2005). HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res. 1045, 57-63.
126. Quinton, M. S., and Yamamoto, B. K. (2006). Causes and consequences of methamphetamine and MDMA toxicity. AAPSJ. 8, E337-E347.
127. Ramirez, S. H., Potula, R., Fan, S., Eidem, T., Papugani, A., Reichenbach, N., Dykstra, H., Weksler, B. B., Romero, I. A., Couraud, P. O., and Persidsky, Y. (2009). Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J. Cereb. Blood Flow Metab. 29, 1933-1945.
128. Ramsauer, M., Krause, D., and Dermietzel, R. (2002). Angiogenesis of the blood-brain barrier in vitro and the function of cerebral pericytes. FASEBJ. 16, 1274-1276.
129. Ransohoff, R. M., Kivisakk, P., and Kidd, G. (2003). Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3, 569-581.
130. Reynolds, J. L., Mahajan, S. D., Bindukumar, B., Sykes, D., Schwartz, S. A., and Nair, M. P. (2006). Proteomic analysisof the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res. 1123, 226-236.
131. Ricaurte, G., Bryan, G., Strauss, L., Seiden, L., and Schuster, C. (1985). Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229, 986-988.
132. Ricaurte, G. A., Forno, L. S., Wilson, M. A., DeLanney, L. E., Irwin, I., Molliver, M. E., and Langston, J. W. (1988). (±)3, 4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA 260, 51-55.
133. Ricaurte, G. A., Schuster, C. R., and Seiden, L. S. (1980). Longterm effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 193, 153-163.
134. Risdahl, J. M., Khanna, K. V., Peterson, P. K., and Molitor, T. W. (1998). Opiates and infection. J. Neuroimmunol. 83, 4-18.
135. Rock, R. B., Gekker, G., Aravalli, R. N., Hu, S., Sheng, W S., and Peterson, P. K. (2008). Potentiation of HIV-1expression in microglial cells by nicotine: involvement of transforming growth factorbeta 1. J. Neuroimmune Pharmacol. 3, 143-149.
136. Rodriguez-Gaztelumendi, A., Alvehus, M., Andersson, T., and Jacobsson, S. O. (2011). Comparison of the effects of nicotine upon the transcellular electrical resistance and sucrose permeability of human ECV304/rat C6 cocultures and human CaCo cells. Toxicol. Lett. 207, 1-6.
137. Romanelli, R. M., Pinto, J. A., Melo, L. J., Vasconcelos, M. A., and Pereira, R. M. (2006). Effectiveness of dual and triple antiretroviral therapy in the treatment of HIV-infected children. J. Pediatr. (RioJ) 82, 260-265.
138. Roth, M. D., Tashkin, D. P., Choi, R., Jamieson, B. D., Zack, J. A., and Baldwin, G. C. (2002). Cocaine enhances human immuno deficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J. Infect. Dis. 185, 701-705.
139. Roth, M. D., Whittaker, K. M., Choi, R., Tashkin, D. P., and Baldwin, G. C. (2005). Cocaine and sigma-1 receptorsmodulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. J. Leukoc. Biol. 78, 1198-1203.
140. Rothman, R. B., and Baumann, M. H. (2003). Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479, 2340.
141. Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, E I., and Partilla, J. S. (2001). Amphetaminetype central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39, 32-41.
142. Samii, A., Nutt, J. G., and Ransom, B. R. (2004). Parkinson's disease. Lancet 363, 1783-1793.
143. Sandoval, K. E., and Witt, K. A. (2008). Bloodbrain barrier tight junction permeability and ischemic stroke. Neurobiol. Dis. 32, 200-219.
144. Schep, L. J., Slaughter, R. J., and Beasley, D. M. (2010). The clinical toxicology of metamfetamine. Clin. Toxicol. (Phila. ) 48, 675-694.
145. Schilling, L., Bultmann, A., and Wahl, M. (1992). Lack of effect of topically applied nicotine on pial arteriole diameter and blood-brain barrier integrity in the cat. Clin. Investig. 70, 210-217.
146. Semple, S. J., Patterson, T. L., and Grant, I. (2004). The context of sexual risk behavior among heterosexualmethamphetamine users. Addict. Behav. 29, 807-810.
147. Sharma, H. S., and Ali, S. E (2006). Alterations in blood-brain barrier function by morphine and methamphetamine. Ann. N Y. Acad. Sci. 1074, 198-224.
148. Sharma, H. S., and Ali, S. E (2008). Acute administration of 3, 4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury. Ann. N Y Acad. Sci. 1139, 242-258.
149. Sharma, H. S., and Kiyatkin, E. A. (2009). Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J. Chem. Neuroanat. 37, 18-32.
150. Sharma, H. S., Muresanu, D., Sharma, A., and Patnaik, R. (2009). Cocaineinduced breakdown of the blood-brain barrier and neurotoxicity. Int. Rev. Neurobiol. 88, 297-334.
151. Sopori, M. L., and Kozak, W. (1998). Immunomodulatory effects of cigarette smoke. J. Neuroimmunol. 83, 148-156.
152. Speer, P., Zhang, Y., Gu, Y., Lucas, M. J., and Wang, Y. (2002). Effects of nicotine on intercellular adhesion molecule expression in endothelial cells and integrin expression in neutrophils in vitro. Am. J. Obstet. Gynecol. 186, 551-556.
153. Stewart, P. A., Hayakawa, K., Akers, M. A., andVinters, H. V. (1992). Amorphometric study of the blood-brain barrier inAlzheimer's disease. Lab. Invest. 67, 734-742.
154. Stolp, H. B., and Dziegielewska, K. M. (2009). Review: Role of developmental inflammation and blood-brain barrier dysfunction in neuro developmental and neurodegenerative diseases. Neuropathol. Appl. Neurobiol. 35, 132-146.
155. Strazza, M., Pirrone, V., Wigdahl, B., and Nonnemacher, M. R. (2011). Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res. 1399, 96-115.
156. Sulzer, D., Sonders, M. S., Poulsen, N. W., and Galli, A. (2005). Mechanisms of neurotransmitter release byamphetamines: a review. Prog. Neurobiol. 75, 406-433.
157. Theodore, S., Cass, W. A., and Maragos, W. E (2006). Methamphetamine and human immunodeficiency virus protein Tatsynergize to destroy dopaminergic terminals in the rat striatum. Neuroscience 137, 925-935.
158. Torres, E., Gutierrez-Lopez, M. D., Mayado, A., Rubio, A., O'Shea, E., and Colado, M. I. (2011). Changes in interleukin-1 signal modulators induced by 3, 4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity. J. Neuroinflammation 8, 53.
159. Uzum, G., Diler, A. S., and Ziylan, Y. Z. (1999). Chronic nicotine pretreatment protects the blood-brain barrieragainst nicotineinduced seizures in the rat. Pharmacol. Res. 40, 263-269.
160. Venisnik, K. M. (2000). Nicotine and cotinine modulate in vitro and in situ blood-brain barrier permeability. Proc. Western Pharm. Soc. 43, 128.
161. Verma, S., and Szmitko, P. E. (2006). The vascular biology of peroxisome proliferatoractivated receptors: modulation of atherosclerosis. Can. I Cardiol. 22(Suppl. B), 12B-17B.
162. Wang, L., Kittaka, M., Sun, N., Schreiber, S. S., and Zlokovic, B. V. (1997). Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats. J. Cereb. Blood Flow Metab. 17, 136-146.
163. Wang, L., McComb, J. G., Weiss, M. H., McDonough, A. A., and Zlokovic, B. V. (1994). Nicotine downregulates alpha 2isoform of Na, K-ATPase at the blood-brain barrier and brain in rats. Biochem. Biophys. Res. Commun. 199, 1422-1427.
164. Webber, M. P., Schoenbaum, E. E., Gourevitch, M. N., Buono, D., and Klein, R. S. (1999). A prospective study of HIV disease progression in female and male drug users. AIDS 13, 257-262.
165. Wisor, J. P., Schmidt, M. A., and Clegern, W. C. (2011). Cerebral microglia mediate sleep/wake and neuroinflammatoryeffects of methamphetamine. Brain Behav. Immun. 25, 767-776.
166. Yamamoto, B. K., and Bankson, M. G. (2005). Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit. Rev. Neurobiol. 17, 87-117.
167. Yamamoto, B. K., and Raudensky, J. (2008). The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetaminerelated drugs of abuse. J. Neuroimmune Pharmacol. 3, 203-217.
168. Yamamoto, Y., Yoshikawa, H., Nagano, S., Kondoh, G., Sadahiro, S., Gotow, T., Yanagihara, T., and Sakoda, S. (1999). Myelinassociated oligodendrocytic basic protein is essential for normal arrangement of the radial component in central nervous system myelin. Eur. J. Neurosci. 11, 847-855.
169. Yang, T., Roder, K. E., Bhat, G. J., Thekkumkara, T. J., and Abbruscato, T. J. (2006). Protein kinase C family members as a target for regulation of blood-brain barrier Na, K, 2Clcotransporter during in vitro stroke conditions and nicotine exposure. Pharm. Res. 23, 291-302.
170. Yang, Y., Yao, H., Lu, Y., Wang, C., and Buch, S. (2010). Cocaine potentiates astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein gp120. PLoS ONE 5, e13427. doi:10.1371/journal.pone.0013427
171. Yao, H., Kim, K., Duan, M., Hayashi, T., Guo, M., Morgello, S., Prat, A., Wang, J., Su, T. P., and Buch, S. (2011). Cocaine hijacks sigma1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS. J. Neurosci. 31, 5942-5955.
172. Yenari, M. A., and Han, H. S. (2012). Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat. Rev. Neurosci. 13, 267-278.
173. Yong, T., Zheng, M. Q., and Linthicum, D. S. (1997). Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse. J. Neuroimmunol. 80, 158-164.
174. Zhang, L., Looney, D., Taub, D., Chang, S. L., Way, D., Witte, M. H., Graves, M. C., and Fiala, M. (1998). Cocaine opens the blood-brain barrier to HIV-1 invasion. J. Neurovirol. 4, 619-626.
175. Zhang, X., Banerjee, A., Banks, W. A., and Ercal, N. (2009). N-Acetylcysteine amide protects against methamphetamineinduced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res. 1275, 87-95.